Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellResearch Consumer Health is the consumer-health and cosmeceutical subsidiary of Singapore-based CellResearch Corporation, commercializing skin and hair care products derived from the parent company's cord lining stem cell technology. The company markets the CALECIM brand, including physician-dispensed and at-home products positioned for post-procedure recovery, anti-aging skincare, and hair restoration support. Its products are based on proprietary stem cell-conditioned media containing growth factors, proteins, and exosome-related components rather than prescription therapeutics. The business appears to operate primarily as a commercial aesthetics and consumer-health company rather than a clinical-stage drug developer, with global distribution through aesthetic physicians, online channels, and regional partners. It is active in Singapore and also has a UK private limited entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CellResearch Consumer Health.